H.R.5074 - Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments Act of 2023 - To delay incorporation of oral drugs indicated for the reduction, management, or control of the serum phosphate of an individual into the End-Stage Renal Disease (ESRD) Prospective Payment System.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ARDELYX, INC.
34175 Ardenwood Boulevard, Freemont, CA, 94555, US
PAUL PEREIRA